Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000088

Chief Medical Officer acquired 10,034 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2023-11-03 Option exercise +10,034 $0.54 $5,418 10,034 D
Derivatives
Rodman David Malcom Chief Medical Officer 2023-11-03 Option exercise · Stock Option −10,034 75,259 D
Loading xslF345X05/wk-form4_1699395330.xml…